What type of stem cell therapy does the Stem Cell Transplant Institute use for spinal cord injuries?

SCTI uses mesenchymal stem cells (MSCs) derived from ethically sourced umbilical cord tissue. These cells are selected for their ability to release biological signals that may help modulate inflammation, support tissue stability, and create a more favorable environment for healing. Your physician will explain the recommended administration route – such as IV infusion or, when clinically appropriate, intrathecal injection – and how it may support your overall care plan.

How much does stem cell therapy for spinal cord injury cost?

Pricing varies depending on the severity of the injury, the number of stem cell applications recommended, and the supportive therapies included. After reviewing your medical history, SCTI will provide a personalized treatment plan with a clear, upfront cost breakdown before moving forward.

How long would I need to stay in Costa Rica for SCI treatment?

Most SCI patients stay 7–10 days, which allows time for evaluation, treatment administration, and short-term follow-up. If multiple sessions or additional supportive therapies are needed, your patient coordinator will help arrange the ideal treatment schedule and travel plan.

Can stem cell therapy help repair spinal cord damage?

Stem cell therapy cannot guarantee regeneration or restored function, but some clinical studies—including early research from Japan where a MSC product is conditionally approved—have reported improvements in certain patients, but outcomes vary widely. Whether you may benefit depends on your specific injury characteristics, overall health, and rehabilitation program. Your doctor will help set realistic expectations for your case.

Will I need surgery as part of the stem cell treatment?

Treatment is typically performed through IV infusion and, when appropriate, intrathecal (spinal) injection. These are minimally invasive procedures designed to minimize discomfort and downtime. Surgery is not typically required for the stem cell application itself.

Can I continue physical therapy or rehabilitation while receiving stem cell treatment?

Yes. Physical therapy is often encouraged as part of a comprehensive recovery plan. Combining rehabilitation with stem cell therapy may help support overall mobility and functional stability by taking advantage of the healthier biological environment MSCs help create. Your medical team will guide you on timing, activity levels, and the most appropriate rehabilitation approach for your specific condition.

What are the possible risks of MSC treatment for SCI?

MSC therapy is generally well tolerated, and most patients experience only mild, short-term effects such as fatigue, headache, or low-grade fever. As with any medical procedure, more serious complications are possible but uncommon. Every patient undergoes a thorough medical evaluation to ensure the treatment is appropriate, and emergency support is available on-site if needed.

Spinal Cord Injury Stem Cell Therapy in Costa Rica

What Is a Spinal Cord Injury?

A spinal cord injury occurs when trauma or disease damages the spinal cord and disrupts communication between the brain and the rest of the body.

Depending on the level and severity of the injury, this interruption can lead to partial or complete loss of movement, sensation, and autonomic function below the affected area. Although surgical care and rehabilitation can support stabilization and recovery, there is currently no treatment capable of fully reversing established spinal cord damage. Cells within the central nervous system have limited capacity for regeneration, which is why long-term symptoms may persist.

According to the World Health Organization (WHO, 2023), 250,000 to 500,000 people worldwide experience a spinal cord injury each year.

Why Seek Stem Cell Therapy for Spinal Cord Injury in Costa Rica?

Stem cell therapy for Spinal Cord Injury is offered at the Stem Cells Transplant Institute in San José, Costa Rica, within a certified clinical facility operating under structured protocols and physician supervision. Programs are designed to accommodate patients across different injury levels and stages of recovery.

Traveling internationally with a spinal cord injury is not a simple undertaking. Pre-travel coordination covers wheelchair accessibility, transfer logistics, attendant care needs, and any respiratory or urological considerations relevant to the patient’s injury level. Patients from the United States, Canada, and Europe choose Costa Rica because the facility is equipped for patients with significant physical limitations, the team has experience across cervical, thoracic, and lumbar profiles, and the cost difference compared to equivalent programs in North America is substantial.

Comprehensive pre-treatment planning includes both clinical and logistical coordination. This process may involve: Injury classification, injury level, time since injury, and current neurological baseline, Review of respiratory, urological, and mobility-related considerations, and planning for accessibility, transfer needs, and caregiver support during travel. Treatment protocols are individualized based on injury characteristics and stage of recovery.

Why Stem Cell Therapy for Spinal Cord Injury?

Research suggests that mesenchymal stem cells (MSCs) can migrate towards areas of spinal cord injury and release protective signals that help modulate inflammation and support tissue stability. These signals may contribute to creating a healthier environment for healing by reducing secondary injury and supporting the natural processes involved in nerve protection and repair.

MSCs have been studied for their potential to limit scarring, promote blood vessel formation, and support the survival of existing nerve cells. By influencing these pathways, stem cell therapy may complement rehabilitation and standard medical care for selected patients living with SCI.

Internationally, MSC-based therapies for spinal cord injury continue to be investigated. In Japan, one MSC product has received conditional, time-limited approval under the country’s regenerative medicine framework for use in selected cases of SCI.

Overall, current evidence remains preliminary and ongoing clinical trials are required to confirm the consistency, magnitude, and long-term impact of these effects.